The field of genetics and the process of testing for genetic disorders have advanced considerably over the past half century, ushering in significant improvements in certain areas of medical diagnosis and disease prediction. However, genetic discoveries are accompanied by many social, emotional, and psychological implications, and counseling psychologists may be uniquely equipped to help clients deal with these issues. The present overview is intended to raise awareness of the multidimensional issues inherent in situations where clients seek genetic testing to diagnose or predict various medical conditions. Initially, the author presents a framework to help counseling psychologists identify and organize information within a genetic-testing context, followed by suggestions for addressing the various psychological, social, and multicultural issues potentially affecting client decision making, mental health, and behavior. Finally, the author raises considerations for training, continuing education, and professional practice to foster continued discussion among counseling psychologists preparing for, or presently working in, research and applied settings involving clients with genetic concerns.
Get full access to this article
View all access options for this article.
References
1.
Altmaier, E. M., Johnson, B. D., & Paulsen, J. S. (1998). Issues in professional identity. In S. Roth-Roemer, S. R. Kurpius, & C. Carmin (Eds.), The emerging role of counseling psychology in health care (pp. 7-29). New York: Norton.
2.
Anderson, N. B., & Nickerson, K. J. (2005). Genes, race, and psychology in the genomic era. American Psychologist, 60, 5-8.
3.
Arevalo, J., Wojcieszek, J., & Conneally, P. M. (2001). Tracing Woody Guthrie and Huntington’s disease. Seminars in Neurology, 21, 209-223.
4.
Baicker, K., Chandra, A., & Skinner, J. S. (2005). Geographic variation in health care and the problem of measuring racial disparities. Perspectives in Medicine and Biology, 48, S42-S53.
5.
Biesecker, B. B. (2001). Goals of genetic counseling. Clinical Genetics, 60, 323-330.
6.
Biller, J. (2002). Practical neurology (2nd ed.). Philadelphia: Lippincott Williams & Wilkins.
7.
Bliss, E. B., Meyers, D. S., Phillips, R. L., Fryer, G. E., Dovey, S. M., & Green, L.A. (2004). Variation in participation in health care settings associated with race and ethnicity. Journal of General Internal Medicine, 19, 931-936.
8.
Bloch, M., Adam, S., Wiggins, S., Huggins, M., & Hayden, M. R. (1992). Predictive testing for Huntington disease in Canada: The experience of those receiving an increased risk. American Journal of Medical Genetics, 42, 499-507.
9.
Bodenhorn, N., & Lawson, G. (2003). Genetic counseling: Implications for community counselors. Journal of Counseling Development, 81, 497-501.
10.
Bonham, V. L., Warshauer-Baker, E., & Collins, F. S. (2005). Race and ethnicity in the genome era (the complexity of constructs). American Psychologist, 60, 9-15.
11.
Codori, A.-M., & Brandt, J. (1994). Psychological costs and benefits of predictive testing for Huntington’s disease. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 174-184.
12.
Collins, R. C. (1997). Neurology. Philadelphia: W. B. Saunders.
13.
DeLong, M. R. (2000). The basal ganglia. In E. R. Kandel, J. H. Schwartz, & T. M. Jessell (Eds.), Principles of neural science (4th ed., pp. 853-867). New York: McGraw-Hill.
14.
deWert, G. (1998). Ethics of predictive DNA testing for hereditary breast and ovarian cancer. Patient Education and Counseling, 35, 43-52.
15.
Dick, D. M., & Rose, R. J. (2002). Behavior genetics: What’s new? What’s next? [Electronic version]. Current Directions in Psychological Science, 11, 70-74.
16.
DudokdeWit, A. C., Tibben, A., Duivenvoorden, H. J., Frets, P. G., Zoeteweij, M. W., Losekoot, M., van Haeringen, A., et al. (1997). Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. Journal of Medical Genetics, 34, 382-390.
17.
DudokdeWit, A. C., Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Passchier, J., Trijsberg, R. W., et al. (1998a). Predicting adaptation to presymptomatic DNA testing for late onset disorders: Who will experience distress?Journal of Medical Genetics, 35, 745-754.
18.
DudokdeWit, A. C., Tibben, A., Duivenvoorden, H. J., Niermeijer, M. F., Passchier, J., Trijsberg, R. W., et al. (1998b). Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: Comparing questionnaire results with in-depth interviews. American Journal of Medical Genetics, 75, 62-74.
19.
Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196, 129-136.
20.
Engel, P. A., & Engel, A. G. (2002). George L. Engel, 1913-1999: Remembering his lifeand work. Strengthening a father-son bond in a new time of grief. Australian and New ZealandJournal of Psychiatry, 36, 443-448.
21.
Evers-Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counseling and for genetic education. Social Sciences & Medicine, 51, 831-841.
22.
Hankey, G., & Wardlaw, J. M. (2002). Clinical neurology. London: Manson.
23.
Hoffman, M. A. (2000). Suicide and hastened death: A biopsychosocial perspective. The Counseling Psychologist, 28, 561-572.
24.
Huggins, M., Bloch, M., Wiggins, S., Shelin, A., Suchowersky, O., Trew, M., et al. (1992). Predictive testing for Huntington disease in Canada: Adverse effects and unexpected results in those receiving a decreased risk. American Journal of Medical Genetics, 42, 508-515.
25.
Huntington’s Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell, 72, 971-983.
26.
Kaut, K. P. (2002). Religion, spirituality, and existentialism near the end of life. American Behavioral Scientist, 46, 220-234.
27.
Kearney, M., & Mount, B. (2000). Spiritual care of the dying patient. In H. M. Chochinov & W. Breitbart (Eds.), Handbook of psychiatry in palliative medicine (pp. 357-373). New York: Oxford University Press.
28.
Kelly, M. P., & Doty, R. E. (1995). Neuropsychological dysfunction: Research and evaluation. In P. M. Nicassio & T. W. Smith (Eds.), Managing chronic illness: A biopsychosocial perspective (pp. 117-162). Washington, DC: American Psychological Association.
29.
Kessler, S. (1994). Predictive testing for Huntington’s disease: A psychologist’s view. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 161-166.
30.
Lenhoff, H. M., Wang, P. P., Greenberg, F., & Bellugi, U. (1997). William’s syndrome and the brain. Scientific American, 277, 68-73.
31.
Lerman, C., Coyle, R. T., Tercyak, K. P., & Hamann, H. (2002). Genetic testing: Psychological aspects and implications. Journal of Consulting and Clinical Psychology, 70, 784-797.
32.
Merluzzi, T. V., & Martinez-Sanchez, M. A. (1998). Psychological perspectives on life-threatening illness: Cancer and AIDS. In S. Roth-Roemer, S. R. Kurpis, & C. Carmin (Eds.), The emerging role of counseling psychology in health care (pp. 157-190).New York: Norton.
33.
Naarding, P., Kremer, H. P. H., & Zitman, F. G. (2001). Huntington’s disease: A review of the literature on prevalence and treatment of neuropsychiatric phenomena. European Psychiatry, 16, 439-445.
34.
Nicassio, P. M., & Smith, T. W. (Eds.). (1995). Managing chronic illness: A biopsychosocial perspective. Washington, DC: American Psychological Association.
35.
Nicholas, D. R., & Veach, T. A. (2000). The psychosocial assessment of the adult cancer patient. Professional Psychology: Research and Practice, 31, 206-215.
36.
Ota Wang, V. (1998). Curriculum evaluation and assessment of multicultural genetic counselor education. Journal of Genetic Counseling, 7, 87-111.
37.
Ota Wang, V., & Sue, S. (2005). In the eye of the storm. Race and genomics in research and practice. American Psychologist, 60, 37-45.
38.
Parker, J. C. (1995). Stress management. In P. M. Nicassio & T. W. Smith (Eds.), Managing chronic illness: A biopsychosocial perspective. Washington DC: American Psychological Association.
39.
Plomin, R. (1998). Using DNA in health psychology. Health Psychology, 17, 53-55.
40.
Plomin, R. (2000). Psychology in a post-genomics world: It will be more important than ever. American Psychological Society Observer, 13,3,27-27.
41.
Plomin, R., & Crabbe, J. (2000). DNA. Psychological Bulletin, 126, 806-828.
42.
Plomin, R., DeFries, J. C., McClearn, G. E., & Rutter, M. (1997). Behavioral genetics (3rd ed.). New York: Freeman.
43.
Quaid, K. A., & Wesson, M. K. (1995). Exploration of the effects of predictive testing for Huntington’s disease on intimate relationships. American Journal of Medical Genetics, 57, 46-51.
44.
Quinn, N., & Schrag, A. (1998). Huntington’s disease and other choreas. Journal of Neurology, 245, 709-716.
45.
Richter, D. (1999). Chronic mental illness and the limits of the biopsychosocial model. Medicine, Health Care and Philosophy, 2, 21-30.
46.
Renzong, Q. (2001). Human genome and philosophy: What ethical challenge will human genome studies bring to medical practices in the 21st century?Academy of Sciences, Paris/Life Sciences, 324, 1097-1102.
47.
Robertson, J., Levinson, C., Mahowald, M., & Walker, A. (2001). BRCA1 screening in a woman with breast cancer: A patient’s perspective with commentary. Women’s Health Issues, 11, 63-72.
48.
Rodier, P. M. (2000). The early origins of autism. Scientific American, 282, 56-63.
49.
Rodriguez, E. R. (1998). Addressing the needs of diverse racial/ethnic populations. In S. RothRoemer, S. R. Kurpius, & C. Carmin (Eds.), The emerging role of counseling psychology in health care (pp. 356-393). New York: Norton.
50.
Roth-Roemer, S., Kurpius, S. R., & Carmin, C. (Eds.). (1998). The emerging role ofcounseling psychology in health care. New York: Norton.
51.
Santrock, J. W. (1999). Lifespan development (7th ed.). Boston: McGraw-Hill.
52.
Silver, A. (2003). Cognitive-behavioural therapy with a Huntington’s gene positive patient. Patient Education and Counseling, 49, 133-138.
53.
Smith, T. W., & Nicassio, P. W. (1995). Psychological practice: Clinical application of the biopsychosocial model. In P. W. Nicassio & T. W. Smith (Eds.), Managing chronic illness: A biopsychosocial perspective (pp. 1-31). Washington, DC: American Psychological Association.
54.
Soldan, J., Street, E., Gray, J., Binedell, J., & Harper, P. S. (2000). Psychologicalmodel for presymptomatic interviews: Lessons learned from Huntington disease. Journal of Genetic Counseling, 9, 15-31.
55.
Sulmasy, D. P. (2002). A biopsychosocial-spiritual model for the care of patients at the end of life. Gerontologist, 42, 24-33.
56.
Taylor, S. D. (2004). Predictive genetic test decisions for Huntington’s disease: Context, appraisal and new moral imperatives. Social Science and Medicine, 58, 137-149.
57.
Tercyak, K. P., Streisand, R., Peshkin, B. N., & Lerman, C. (2000). Psychosocial impact of predictive testing for illness on children and families: Challenges for a new millennium. Journal of Clinical Psychology in Medical Settings, 7, 55-68.
58.
Thoresen, C. E., & Hoffman-Goldberg, J. (1998). Coronary heart disease: A psychosocial perspective. In S. Roth-Roemer, S. R. Kurpius, & C. Carmin (Eds.), The emerging role of counseling psychology in health care (pp. 94-136). New York: Norton.
59.
Thull, D. L., & Vogel, V. G. (2004). Recognition and management of hereditary breast cancer syndromes. The Oncologist, 9, 13-24.
60.
Tibben, A., Frets, P. G., van de Kamp, J. J. P., Niermeijer, M. F., der Vlis, M. V., Roos, R. A. C., et al. (1993). On attitudes and appreciation 6 months after predictive DNA testing for Huntington’s disease in the Dutch program. American Journal of Medical Genetics (Neuropsychiatric Genetics), 48, 103-111.
61.
Tiley, N. A. (1983). Discovering DNA: Meditations on genetics and a history of the science. New York: Van Nostrand Reinhold.
62.
Van Riper, M., & McKinnon, W. C. (2004). Genetic testing for breast and ovarian cancer susceptibility: A family experience. Journal of Midwifery and Women’s Health, 49, 210-219.
63.
Walsh, A. (1999). Presymptomatic testing for Huntington disease: The role of genetic counseling. Medicine and Health/Rhode Island, 82, 168-170.
64.
Wang, C., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: Current research and future directions. Social Science and Medicine, 58, 1427-1442.
65.
Watson, J. D., & Crick, H. C. (1953). Genetic implications of the structure of deoxyribonucleic acid. Nature, 171, 964-969.
66.
Weil, J. (2001). Multicultural education and genetic counseling. Clinical Genetics, 59, 143-149.
67.
Young, K., & Zane, N. (1995). Ethnocultural influences in evaluation and management. In P. W. Nicassio & T. W. Smith (Eds.), Managing chronic illness: A biopsychosocial perspective(pp. 163-206). Washington, DC: American Psychological Association.
